Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1157804Generated: November 1, 2026

Methanesulfonic Acid → benzyl 4-(1-(pyridin-2-yl)-1H-pyrazol-5-yl)piperazine-1-carboxylate

https://huagongshe.com/reaction/1157804

Reaction equation

Participants

RoleNameHCIDCharge
ReactantMethanesulfonic AcidHCID 6395—
ReactantTrifluoroacetic acidHCID 6422—
ReactantPhosphorus oxychlorideHCID 24813—
Reactant2-HydrazinopyridineHCID 78645—
ReactantBenzyl 4-(3,3-diethoxypropanoyl)piperazine-1-carboxylateHCID 23014298—
SolventWaterHCID 962—
SolventPyridineHCID 1049—
SolventChloroformHCID 6212—
Productbenzyl 4-(1-(pyridin-2-yl)-1H-pyrazol-5-yl)piperazine-1-carboxylateHCID 6869377511.2%

Reaction Conditions

Temperature25 °C

Reaction Steps

Part B: To a solution of benzyl 4-(3,3-diethoxypropanoyl)piperazine-1-carboxylate (3.39 g, 9.30 mmol) in 30 mL of chloroform at 0° C. was added a solution of 10.0 mL of water and 10.0 mL of trifluoroacetic acid, and the resulting biphasic mixture was stirred at 25° C. for 20 h. The mixture then was diluted with additional chloroform, washed with water and brine, dried over anhydrous sodium sulfate, filtered, and concentrated. The residue then was dissolved in 50 mL of ethanol. To this solution was added 2-hydrazinopyridine (1.015 g, 9.30 mmol) and methanesulfonic acid (0.060 mL, 0.930 mmol), and the resulting mixture was stirred at 25° C. for 18 h. Pyridine (1.00 mL) was added, and then the reaction mixture was concentrated under vacuum. The residue was dissolved in 50 mL of pyridine. To this solution was added phosphorous oxychloride (1.73 mL, 18.6 mmol), and the mixture was stirred at 25° C. for 20 h. The mixture was concentrated under vacuum. The residue was diluted with water and ethyl acetate, and the phases were separated. The organic phase was washed with water and brine, dried over anhydrous sodium sulfate, filtered, and concentrated. Column chromatography on silica gel (elution: 10-50% ethyl acetate/methylene chloride) afforded 0.38 g (11.2%) of benzyl 4-(1-(pyridin-2-yl)-1H-pyrazol-5-yl)piperazine-1-carboxylate as an oil; Mass Spec.: m/e: 364.20 (M+H)+ [calc'd: 364.18]; 1H NMR (500 MHz, DMSO-D6) δ 8.53 (d, 1H, J=5.0 Hz), 7.97 (t, 1H, J=8.0 Hz), 7.73 (d, 1H, J=8.0 Hz), 7.58 (s, 1H), 7.40-7.30 (m, 6H), 6.04 (s, 1H), 5.10 (s, 2H), 3.49 (m, 4H), 2.94 (m, 4H).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07807676B2
Source datasetuspto-grants-2010_10
ORD IDord-c77d592b27e344999333046974fbd88f
Source noteuspto-grants-2010_10